Liabilities / Assets
72nd percentile
Higher debt load relative to assets than 72% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.33x
Liabilities / Revenue
44th percentile
Higher debt load relative to revenue than 44% of similar nonprofits.
Net Margin
9th percentile
Higher net margin than 9% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
1st percentile
Faster asset growth than 1% of similar nonprofits.
Revenue Growth
23rd percentile
Faster revenue growth than 23% of similar nonprofits.
Balance Sheet
Assets
Down$263,982
Down $356,659 (-57%) from 2016
Net Assets
Down$177,692
Down $374,574 (-68%) from 2016
Liabilities
Up$86,290
Up $17,915 (+26%) from 2016
Revenue And Expenses
Revenue
Down$1,161,154
Down $92,926 (-7.4%) from 2016
Expenses
Up$1,535,728
Up $833,914 (+119%) from 2016
Net Income
Down-$374,574
Down $926,840 (-168%) from 2016
Historical Trend
Filing Detail Status
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2016 to Jun 30, 2017
Mission and Program Overview
Mission
The organization is a partnership of world leaders in als research and care focused on expediting breakthrough treatments and ultimately a cure for als while providing resources and equipment to those living with the disease now. The team of als researchers, doctors, and care practitioners is uniquefor its leadership in efficiency, dedication to innovative research, and commitment to increasing access to care and treatment.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $263,982
- Liabilities
- $86,290
- Net assets
- $177,692
- Revenue
- $1,161,154
- Expenses
- $1,535,728
- Net income
- -$374,574